Welcome to the Ennovation Podcast, where we bring you the latest trends, insights and expertise in life sciences and regulatory affairs.
…
continue reading
RCA Radio covers the latest news and challenges in regulatory, compliance, and quality assurance facing the medical device, pharmaceutical, and biologic industries. In each episode, join Regulatory Compliance Associates® (RCA) and industry thought leaders as we navigate the issues that matter to you most.
…
continue reading
Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues ...
…
continue reading
A Ropes & Gray (RopesTalk) podcast series, focused on current trends in FDA regulatory law, as well as other important developments affecting the life sciences industry.
…
continue reading
Gradical is the plastics expert for medical technology. We help medical technology companies to select the right plastic for their application. This takes into account technical suitability, regulatory requirements and sustainability aspects. The Gradical podcast covers all topics relating to plastics in medical technology. Sustainability, sterilization, the medical grade concept, biocompatibility and many other topics await you in this podcast. The host Lucas Pianegonda is a plastics expert ...
…
continue reading
Life Sciences 360 is an interview show that educates anyone on challenges, trends, and insights in the life-sciences industry. Hosted by Harsh Thakkar, a life-sciences industry veteran and CEO and co-founder of Qualtivate, the show features subject-matter experts, business leaders, and key life-science partners contributing to bringing new therapies to patients worldwide. Harsh is passionate about advancements in life sciences and tech and is always eager to learn from his guests— making the ...
…
continue reading
Learn from the brightest CEOs in medtech and healthtech. That's our primary goal with Medsider. We unpack the strategies, tactics, and secrets behind the most successful startups. Join tens of thousands of ambitious doers and get access to the top medical device and health technology thought leaders.
…
continue reading
Stories from the front lines of life sciences. Hear how founders, investors, engineers, scientists, and quality experts are innovating to save lives. You’ll hear founders share their insights from launching and scaling their business, investors giving their outlook on funding, industry experts unfolding their latest insights and research, and quality professionals offering advice to navigate the regulatory maze and avoid audit pitfalls. We interview the brightest people in the life sciences ...
…
continue reading
RQM+ industry-leading experts and often special guests discuss regulatory, quality, clinical, lab, and reimbursement challenges MedTech companies are facing. RQM+ is the world's leading MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle. With more former FDA, Medicines, and Healthcare Products Regulatory Agency (MHRA) and notified body regulators than any other firm, the RQM+ t ...
…
continue reading
A podcast focused on the medical device technology industry, from design and development to outsourcing services and relationships to finished medtech products.
…
continue reading
Your local digital health ecosystem is a bubble. There’s a much bigger picture out there. What if you could learn from people working on similar problems in other contexts? This is the podcast that focuses on real, practical learnings for vendors, researchers and policy folk working for responsible AI and digital health with underserved communities. Join digital health leader Dr Shubs Upadhyay who has worked across the ecosystem as we unpack the insights of people serving underserved communi ...
…
continue reading
Where MedTech and Sci-Fi Collide! In The Circle Podcast we welcome you into the world of innovators & leaders from the Medical and Health Technology space. Through the projectionlens of Sci-Fi stories, prepare to meet, the who's who in the Medicon Valley... Circle! ---------------------- Hosted by Faisal Kamal Faisal holds a Masters Degree in Pharmaceutical Science from Copenhagen University, where he has acted as an external lecturer. Faisal is an experienced Regulatory Affairs professional ...
…
continue reading
Presented by Kymanox, Life Science Solutions is dedicated to accelerating understanding and advancing expertise in the life sciences industry. Focused on bringing industry insights to light, our podcast offers a platform where regulatory, scientific, and engineering experts share practical knowledge on overcoming the challenges of product development and commercialization. Episodes equip listeners with the latest on regulatory updates, market trends, cutting-edge technology, and more. Join u ...
…
continue reading
We help medical device professionals deepen their knowledge of customers, the industry, and their role. Our main objective is to help you become expert in your current position, and through a better understanding of others within your company and the best practices in others in the industry, enable you to fast-track your career.
…
continue reading
Driving the Business of Science is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world. Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step. In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insig ...
…
continue reading
FDA Watch is a twice-monthly, national podcast that provides an independent, non-partisan forum for discussing and understanding the latest developments, trends, and issues involving FDA. The podcast focuses on four core areas: pharmaceuticals and biologics; medical devices and diagnostics; food and dietary supplements; and cosmetics and personal care products, as well as on the overall direction of FDA regulation. The podcast also will have bonus episodes to cover breaking news. Podcast gue ...
…
continue reading
Welcome to the Lattice podcast, the official podcast for 3DHEALS. This is where you will find fun but in-depth conversations (by founder Jenny Chen) with technological game-changers, creative minds, entrepreneurs, rule-breakers, and more. The conversations focus on using 3D technologies, like 3D printing and bioprinting, AR/VR, and in silico simulation, to reinvent healthcare and life sciences. This podcast will include AMA (Ask Me Anything) sessions, interviews, select past virtual event re ...
…
continue reading
Progress occurs when thought leaders share insights and knowledge at the cutting edge of sports medicine...so we’re inviting renowned surgeons and industry experts to lead the conversation. The Joint Ventures podcast series puts the hot topics center stage, so stay tuned to explore evolving trends, shifting perceptions and emerging procedural technologies. DISCLAIMER: Smith+Nephew is a medical device manufacturer and does not provide medical advice. This material may contain information rela ...
…
continue reading
Host Eugene Borukhovich explores how non-molecular therapies and interventions can prevent, manage or even cure diseases. Learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing this industry.
…
continue reading
Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech and Biopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia. What You’ll Learn: Speed Secrets: How to secure ethic ...
…
continue reading
Hogan Lovells is always thinking about how to conquer and foresee the most significant industry issues facing our clients. If you’ve been following us for the past two years, you’ve heard first-hand from our lawyers around the world on significant developments in the Life Sciences & Health Care sector and why they are so passionate about the industry. In season 3, we’ll unpack new and exciting industry trends and bring you more outside perspectives to keep you ahead of the curve.
…
continue reading
Podcast by Taylor & Francis Group
…
continue reading
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
…
continue reading
The Health Care Law Today Podcast, presented by Foley & Lardner LLP, is your connection to timely health care legal updates. Topics will cover a wide range of legal issues including Digital Health and Telemedicine, Regulatory and Compliance, Mergers & Acquisitions, Private Equity, Venture Capital and so much more. Each episode, a Foley attorney will be paired with a thought leader to discuss legal trends currently affecting the health care industry. It is important to note that this podcast ...
…
continue reading
Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechnology sector.
…
continue reading
Welcome to the International Pharma Talks, powered by ELS Solutions Group, a podcast hosted by Dr. Diogo Sousa-Martins, Ph.D., MBA. This podcast will dive deep into the world of pharma & healthcare international business where you will learn strategies and action plans to help you navigate through your internationalization program and achieve the best results. If you wish to develop your international program in pharma, healthcare or medtech areas or to register or distribute your products i ...
…
continue reading
The Pharmadelic Experience podcast explores career opportunities in the pharma sector. Each episode will focus on a different career field, so you can learn what they do, how they got there and what challenges they have encountered along the way. For inquiries email: [email protected]
…
continue reading
At the Save Our Sites (SOS) conference, many site owners expressed excitement over finally having a space to openly discuss real challenges—budgets, pricing, contracting, and the isolation of being a site owner. While the intent was mutual support, concerns quickly arose when some attendees began advocating for standardized pricing across sites (e.…
…
continue reading

1
Self-Fulfilling Prophecy with Anne Skare Nielsen - Star Trek
29:14
29:14
Play later
Play later
Lists
Like
Liked
29:14By Faisal Kamal
…
continue reading
The recent conviction of a Michigan pharmacist and his brother in a $15 million healthcare fraud scheme highlights the growing crackdown on pharmacy-related fraud. The scheme involved billing for medications that were never dispensed, targeting Medicare, Medicaid, and private insurance. This pattern of fraud is not new, as the Department of Justice…
…
continue reading

1
Challenging the Gold Standard: Interview with Profound Medical CEO Arun Menawat
50:57
50:57
Play later
Play later
Lists
Like
Liked
50:57In this episode of Medsider Radio, we sat down with Dr. Arun Menawat, Chairman and CEO of Profound Medical. Profound is commercializing the TULSA-PRO system, an alternative approach to prostate cancer treatment that uses MRI-guided thermal ultrasound to target and eliminate cancerous tissue without surgical incisions. Before joining Profound in 201…
…
continue reading

1
4.5 Billion Molecules, One Mission: Cure the ‘Undruggable’ Diseases
30:57
30:57
Play later
Play later
Lists
Like
Liked
30:57Solving the “Undruggable” Disease Problem with Goldilocks Molecules In this episode, Christian Schafmeister, Founder and President of Third Law Molecular, reveals a new class of therapeutics designed to target what most consider “undruggable” diseases—conditions like Alzheimer’s, certain cancers, and rare genetic disorders. Christian explains the s…
…
continue reading
Implementation. What does it mean? Why is it hard? How do we get it right? Failure. Are we, in Global Digital Health, thinking and acting in a way that doesn't help us move forward? Caroline Perrin, Director of the Geneva Digital Health Hub joins us on the Global Perspectives on Digital Health podcast to share her views on this. This episode is for…
…
continue reading

1
503 Compounding: Challenges, Compliance & the Road Ahead
16:56
16:56
Play later
Play later
Lists
Like
Liked
16:56In this episode of RCA Radio, host Brandon Miller is joined by RCA experts Anita Michael and Arie Anahory for a deep dive into the evolving world of compounding pharmacies. Together, they explore the critical role compounders play in personalized medicine, their differences from traditional pharmaceutical manufacturers, and the increasing regulator…
…
continue reading
Pharma is finally catching up to the on-demand world—offering direct-to-patient (DTP) services that promise convenience, faster delivery, and a more personalized experience. Major players like Pfizer, Lilly, and Novo Nordisk are leading the way, cutting out intermediaries like pharmacists, PBMs, and even traditional physicians. But convenience come…
…
continue reading
Today, we're diving into a hot topic in clinical trials: should you use AI to negotiate your next clinical trial agreement? Darshan is joined by Elizabeth from the University of Cincinnati and Istvan Fekete from Huron Consulting, who share their experiences and thoughts on using AI for contract and budget negotiations. They discuss the potential an…
…
continue reading

1
A cure worse than the disease? Using tariffs to bolster U.S. pharma manufacturing
27:54
27:54
Play later
Play later
Lists
Like
Liked
27:54In this episode of Talking the Cure, Phil Katz talks with Cybil Roehrenbeck, Josh Gelula, and Kelly Zhang about the announced and seemingly ever-changing plans for tariffs on imported goods – and pharmaceutical products in particular – may effect the industry, as well as the availability and cost of drugs. The discussion unpacks the law, the politi…
…
continue reading
In this discussion, Edye Edens and Darshan Kulkarni tackle one of the most common questions in clinical research: How many SOPs should a site have? While many assume a fixed number like 12, the reality is more nuanced. From a site perspective, having extensive SOPs can feel overwhelming, but they are essential for compliance and audits. SOPs are th…
…
continue reading

1
Trends in False Advertising and Related Competitor Disputes Involving FDA-Regulated Products
17:55
17:55
Play later
Play later
Lists
Like
Liked
17:55On this special collaborative episode of Ropes & Gray's Non-binding Guidance and Talkin’ Trade podcast series, life sciences regulatory and compliance partner Josh Oyster is joined by intellectual property litigation partner Matt Rizzolo to discuss the complex world of false advertising and unfair competition disputes involving drugs, medical devic…
…
continue reading

1
Episode #84 | Tuan Tranpham On 3D Printing Mega-Trends
58:55
58:55
Play later
Play later
Lists
Like
Liked
58:55Tuan Tranpham shares his extraordinary journey from Vietnamese refugee to 3D printing industry leader, offering unique insights on industry evolution, technological innovation, and future trends. His global perspective bridges Eastern and Western manufacturing approaches while highlighting continuous carbon fiber printing opportunities and microfac…
…
continue reading

1
Breaking Down Barriers in Women's Health: Interview with Neuraura CEO Claire Dixon
53:32
53:32
Play later
Play later
Lists
Like
Liked
53:32In this episode of Medsider Radio, we sat down with Claire Dixon, CEO of Neuraura. Neuraura is developing LoOop, an over-the-counter wearable that targets PCOS through low-frequency electrical stimulation. Claire brings over 25 years of international leadership experience to her role as co-founder and CEO of Neuraura. With a master's degree in engi…
…
continue reading
In a recent interview between Nirpal Virdee and Darshan Kulkarni, they discussed the ongoing shifts in the pharmaceutical industry, particularly the rise of Direct-to-Patient (DTP) models. The conversation explored how these changes are driven by the pressure to reduce drug and device costs, especially in light of new tariffs that could further esc…
…
continue reading

1
From crisis to revolution. Why Africa's moment is now, a healthtech VC's case.
1:04:21
1:04:21
Play later
Play later
Lists
Like
Liked
1:04:21A healthtech investor's view on healthcare in Africa in the next 10 years. If you’re building or investing for impact with underserved communities in Africa, this episode is for you. Rowena Luk has walked the talk. She is the ‘OG’ of creating visibility on digital health in Africa, and has built and scaled for impact in over 40 countries on the con…
…
continue reading
In this episode of Driving the Business of Science, Elevating Life Science Meetings & Events, Keith Parent, CEO of Court Square Group, discusses with Sam Ali, co-founder of Precision Evolution Global, the importance of attending and participating in industry events. Effective industry events aimed at decision-makers in pharma, biotech, and CROs, co…
…
continue reading

1
Hunting the perfect molecule with Dr. James Field, CEO of LabGenius Therapeutics
23:17
23:17
Play later
Play later
Lists
Like
Liked
23:17Today we’re heading across the Atlantic to speak to Dr. James Field, CEO of London-based LabGenius Therapeutics. LabGenius has a really exciting mission. James and his team of 60 scientists and engineers believe in the powerful combination of human and artificial intelligence, and are pioneering an ML-driven protein engineering platform - EVA - tha…
…
continue reading

1
Hackers Are Stealing Your Personal Health Data
1:29
1:29
Play later
Play later
Lists
Like
Liked
1:29Health records are one of the top targets for hackers. These records contain a wealth of personal information like Social Security numbers, insurance details, and medical history, making them a gold mine for cybercriminals. Hackers use this data to steal identities, open credit cards, and even file fake tax returns. The scariest part? They can crea…
…
continue reading

1
How a “Medical Education” Program Became a $202M Fraud
3:01
3:01
Play later
Play later
Lists
Like
Liked
3:01We unpack the $202 million storm surrounding Gilead’s so-called “educational” speaker programs — and why it should make every medical affairs, legal, marketing, and compliance professional sit up straight. Here’s what happened: The DOJ alleged that Gilead turned 17,000 speaker programs into a covert marketing machine to boost HIV drug prescriptions…
…
continue reading

1
Episode #83 | Ceramics, Conferences, and the Future of 3D Printing With Craig Rosenblum
49:31
49:31
Play later
Play later
Lists
Like
Liked
49:31When EOS president Glynn Fletcher declared "3D printing is cool, but cool is not a business model" at Rapid TCT 2025, he captured the evolution across the additive manufacturing landscape. In this eye-opening conversation with Craig Rosenblum, president of Himed, we explore how the industry matures beyond technological demonstrations toward practic…
…
continue reading

1
Webinar Recap: What Sponsors Must Know About Fraud
4:06
4:06
Play later
Play later
Lists
Like
Liked
4:06After our first-ever deep dive webinar on ‘Protecting Sponsors, Fraud & Compliance in Research,’ Darshan Kulkarni, Edye Edens, and Nirpal Virdee sat down to reflect on what turned out to be a high-impact and incredibly timely conversation. Nirpal (the newest face on the team, leading business development) shared how exciting it was to finally launc…
…
continue reading

1
AI, Medical Products & FDA, Part 2: AI Discovery, Design & Development
43:54
43:54
Play later
Play later
Lists
Like
Liked
43:54In this second part of our AI-focused series in collaboration with Arnold & Porter, Shelly and Wayne chat with Howard Sklamberg, Partner at Arnold & Porter; Eva Temkin, Partner at Arnold & Porter; and Marko Topalovic, Chief AI Officer at Clario, which recently acquired ArtiQ, where he was Founder and CEO. Together, they discuss how AI can accelerat…
…
continue reading

1
What Separates Life Science Startup Winners from Losers?
38:46
38:46
Play later
Play later
Lists
Like
Liked
38:46Why Startups Fail (Hint: It’s Not the Innovation) In this episode, Carlo Odicino, CEO and Founder at One TEAM Partners, shares the real reasons why most early-stage life sciences companies struggle to survive—and it has nothing to do with bad science. Learn the hidden pitfalls of scaling too fast, confusing innovation with execution, and chasing to…
…
continue reading

1
Taking Retinal Imaging Beyond Ophthalmology: Interview with identifeye HEALTH CEO Vicky Demas
53:46
53:46
Play later
Play later
Lists
Like
Liked
53:46In this episode of Medsider Radio, we sat down with Vicky Demas, CEO of identifeye HEALTH (formerly Tesseract Health), who's leading the company's efforts to democratize access to retinal imaging. Using advanced algorithms and automated systems, identifeye's technology captures and analyzes retinal images to detect early signs of disease. Before jo…
…
continue reading
AI voice tech might be the next big privacy risk for pharma marketers, and lawsuits are already in motion. In this episode of Darshan Talks, we dive into the legal challenges surrounding AI-powered voice tools in healthcare marketing, especially under California’s strict privacy laws. A federal court ruling in Ambrose v. Google suggests that record…
…
continue reading

1
Episode #82 | Advancing Microfluidic Technology Through 3D Printing (Virtual Event Recording)
1:31:39
1:31:39
Play later
Play later
Lists
Like
Liked
1:31:39Peering into the microscopic world of fluid channels just got a revolutionary upgrade. At this 3DHEALS event, we explore the transformative impact of 3D printing on microfluidic device development with industry experts and researchers at the cutting edge of this technology convergence. Our speakers share how specialized 3D printing systems are over…
…
continue reading
Welcome back to the Ennovation Podcast, where we bring you the latest trends, insights, and expertise in life sciences and regulatory affairs. This time, I’m joined by Pierre Stanislawski, our IDMP expert, and Josh Keliher, who’s leading the charge on AI at Ennov. Together, we dive into two major questions: what does AI really mean for regulatory a…
…
continue reading
Shelly and Wayne chat with Dr. Daniel Schultz, Principal of Medical Devices and Combination Products at Eliquent, and Jonathan Kahan, a Global Regulatory Partner at Hogan Lovells. You’ll hear their thoughts on the effect of CDRH staff reductions on medical device reviews and market authorizations; the outlook for device regulation in the next few y…
…
continue reading

1
Webinar Update: Fraud Prevention Strategies Every Sponsor Needs
7:14
7:14
Play later
Play later
Lists
Like
Liked
7:14Event details- https://www.linkedin.com/events/protectingsponsors-fraudandcomp7318667647213002752/comments/ Registration Link- https://us02web.zoom.us/meeting/register/KhsVL6C6Tg6KKNDRHYTEKA In this kickoff conversation, Darshan Kulkarni and Edye Edens introduce a candid new series exploring how legal and compliance professionals approach clinical …
…
continue reading
Dr. Chris DeArmitt is a world-class Plastic consultant and independent environmental expert. Chris had a stellar career in the plastics industry at firms such as BASF before starting his own consultancy Phantom Plastics. In 2020 he wrote the plastics paradox, where he tackles persistent myths about the environmental impact of plastics. He founded a…
…
continue reading

1
Are Your Promotional Claims Putting Your Company at Risk?
1:38
1:38
Play later
Play later
Lists
Like
Liked
1:38Guardant Health’s recent $292 million victory against Natera in a false advertising lawsuit sets a critical precedent for the biotech industry, highlighting the severe consequences of misleading claims. This case is a wake-up call for drug and device companies navigating complex FDA and FTC regulations. False advertising not only misleads stakehold…
…
continue reading

1
Pandora's Box of Secrets EXPOSED in Drug Pricing Transparency!
30:15
30:15
Play later
Play later
Lists
Like
Liked
30:15The Hidden Math Behind Drug Pricing: Why Patients Pay More Than They Should In this episode, Michael Grosberg, VP of Product Management at Model N, breaks down the complex drug pricing ecosystem—revealing how rebates, PBMs, and outdated pricing models shape what patients actually pay. You’ll learn how Pharmacy Benefit Managers (PBMs) really operate…
…
continue reading

1
Elevating the standard of care in knee repair
37:16
37:16
Play later
Play later
Lists
Like
Liked
37:16Get expert perspectives on treating the entire knee from leading surgeons and the UFC Performance Institute’s Senior Director of Physical Therapy. With the aim of getting their patients back to their lives, the panel explains why they consider multiple aspects of knee preservation: ligament reconstruction (quad grafts, LET and multi-ligament), meni…
…
continue reading

1
Capturing Venture Capital: What Makes Life Science Startups Stand Out to Investors
27:52
27:52
Play later
Play later
Lists
Like
Liked
27:52In this special episode recorded live at CED Venture Connect, host Chris Adkins sits down with Dave Ousterout, Co-Founder and General Partner at CapeFear Biocapital. Drawing from his unique journey as both a biotech entrepreneur and now a venture capital investor, Dave shares what it really takes to stand out in the early-stage life sciences space.…
…
continue reading
Keith Parent, CEO of Court Square Group, discusses the business aspects of drug development with James Blackwell, Ph.D., MBA, President of Windshire Group. They explore the importance of quality in life science, emphasizing the need for a holistic approach beyond compliance. Blackwell highlights the significance of modality-agnostic strategies, the…
…
continue reading

1
Regulatory strategy for founders and policy makers
55:08
55:08
Play later
Play later
Lists
Like
Liked
55:08Practical breadth and depth on the global state of regulation from someone at the cutting edge of regulatory policy. Shubs welcomes Hugh Harvey, founder of Hardian Health and a regulatory expert in digital health. Shubs and Hugh discuss the complex landscape of medical device regulation worldwide, with emphasis on how these frameworks impact digita…
…
continue reading

1
Breaking Down Pharma in the Current Environment
46:24
46:24
Play later
Play later
Lists
Like
Liked
46:24Shelly and Wayne chat with Dr. Michelle McMurry-Heath, Founder and CEO of BioTechquity Clinical, and Alan Minsk, Partner, Chair of the Food & Drug practice, and Co-Chair of the Life Sciences industry team at Arnall Golden Gregory LLP. You’ll hear their thoughts on the potential effects that FDA staffing cuts may have on drug and biologics approvals…
…
continue reading

1
Privacy Dangers Lurking in Clinical Trial Mergers
5:45
5:45
Play later
Play later
Lists
Like
Liked
5:45Darshan Kulkarni and Edye Edens discuss the critical role of data privacy in clinical trial site acquisitions. While privacy concerns can seem daunting, they don’t have to be a dealbreaker if managed correctly. The key is understanding whether privacy laws like HIPAA apply, ensuring the site is already handling data compliance well, and putting saf…
…
continue reading

1
Episode #81 | From J&J to the Future: Sam Onukuri's 30-Year Adventure in 3D Printed Medical Devices
1:20:55
1:20:55
Play later
Play later
Lists
Like
Liked
1:20:55Sam Onukuri takes us through his remarkable 30-year journey at Johnson & Johnson, where he transformed the landscape of medical devices through pioneering work in 3D printing technology. As a material scientist who led the development of J&J's Center of Excellence for additive manufacturing, Sam offers rare insights into how a global healthcare gia…
…
continue reading
The FDA you designed your protocol around may no longer exist. In this episode, Darshan Kulkarni breaks down why clinical researchers, regulatory attorneys, and promotional review teams need to pay attention—now. With mass layoffs, frozen guidances, and a reorganization shaking CDER and CBER to their core, trial timelines, IRB reliance, and even le…
…
continue reading

1
The State of Protection, Innovation & Communication at FDA
33:46
33:46
Play later
Play later
Lists
Like
Liked
33:46Shelly and Wayne chat with Ron Bartek, Co-Founder and President of Friedreich’s Ataxia Research Alliance, and Ralph Hall, CEO of Hall Strategies, LLC. Together, they discuss the overall situation at FDA right now; its impact on agency activities and innovation; what areas will be most impacted; what policy changes, such as those surrounding vaccine…
…
continue reading

1
Building the Beachhead Strategy: Interview with Axena Health Leaders Randy Pritchard and Erica Rogers
55:01
55:01
Play later
Play later
Lists
Like
Liked
55:01In this episode of Medsider Radio, we sat down with Randy Pritchard and Erica Rogers, leaders of Axena Health. Axena is transforming pelvic floor therapy with Leva, a device bringing clinically-proven, supervised pelvic floor muscle training into women’s homes. Randy, CEO of Axena, brings nearly 25 years of healthcare experience to the company, mos…
…
continue reading

1
A CCO’s Brutally Honest Advice if You Want to Succeed in Pharma Commercialization
31:45
31:45
Play later
Play later
Lists
Like
Liked
31:45Early Commercialization Strategies That Actually Work (Especially for Startups!) In this episode, John Harlow, Chief Commercial Officer at Melinta Therapeutics, shares real-world strategies for how lean pharma startups can win the commercialization game—without Big Pharma budgets. Discover how small companies can pivot fast, creatively optimize dis…
…
continue reading
The FDA is facing unprecedented turmoil—staff cuts, a sweeping reorganization, and political interference are undermining its ability to safeguard public health. Former agency leaders are raising red flags, with one likening the situation to "flat earthers taking over NASA." With vaccine data access becoming politicized, stem cell oversight potenti…
…
continue reading

1
Health First, Innovation Second. Smisha Agarwal on what needs to change in global digital health.
44:43
44:43
Play later
Play later
Lists
Like
Liked
44:43Dr. Smisha Agarwal (Johns Hopkins University Global Center for Digital Health Innovation) joins me to unpack some hard truths on the Global Perspectives on Digital Health podcast. 🛑 Why global health systems remain fragile 📉 How digital tools often scale without legitimacy 📊 What’s wrong with our fixation on "did it work?" and significance values 🔁…
…
continue reading

1
AI, Medical Products & FDA, Part 1: AI Overview in Life Sciences
47:16
47:16
Play later
Play later
Lists
Like
Liked
47:16In this first part of our AI-focused series in collaboration with Arnold & Porter, Shelly and Wayne chat with Dan Kracov, Partner at Arnold and Porter and Chair of the firm’s Global Life Sciences Industry group; Abeba Habtemariam, Partner at Arnold & Porter; Ethan Dabbs, Managing Director and Senior Partner at the Boston Consulting Group; and Laure…
…
continue reading

1
You are now the Healthcare Provider - The Future of Health Insurance: Trends, Challenges, and Innovations
14:52
14:52
Play later
Play later
Lists
Like
Liked
14:52In this episode, Kate Woods and Darshan Kulkarni discussed the shift from employer-sponsored health insurance to individual responsibility, a transition accelerated by policy changes and rising healthcare costs. Traditionally, employer-provided insurance has been the backbone of the U.S. healthcare system, but evolving regulations, including the Af…
…
continue reading

1
Episode #80 | Live from San Francisco: Innovation in 3D Printing & Bioprinting
1:29:57
1:29:57
Play later
Play later
Lists
Like
Liked
1:29:573DHEALS kicked off its first in-person/hybrid event in 2025 in San Francisco, welcoming investors, entrepreneurs, and innovators in the space. The healthcare industry is transforming, driven by 3D printing and bioprinting technologies redefining patient care. This exclusive in-person hybrid event offered an opportunity to explore the latest advance…
…
continue reading

1
Essential Due Diligence Steps for Clinical Research M&A
3:45
3:45
Play later
Play later
Lists
Like
Liked
3:45When mergers and acquisitions intersect with clinical trials, due diligence becomes a crucial step in ensuring a successful transition. In this insightful discussion, Darshan Kulkarni and Edye Edens explore the key legal and operational considerations when acquiring or merging with clinical research entities, including sponsors, sites, and CROs. A …
…
continue reading